TLX News: Telix Expands Lutetium-177 Network with Eckert & Ziegler Clinical Supply Agreement - 9th Feb 2022, 9:27am

[zeeb0t]

MELBOURNE and LIEGE, Belgium, Feb. 08, 2022 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces a global clinical supply agreement with Berlin-based Eckert & Ziegler Strahlen- und Medizintechnik AG (EZAG) for highly pure no-carrier-added (n.c.a.) lutetium-177 (177Lu), a therapeutic isotope used in Telix’s portfolio of molecularly targeted radiation (MTR) investigational products.

This agreement further enhances Telix’s existing 177Lu suppli...

>>> Read more: Telix Expands Lutetium-177 Network with Eckert & Ziegler Clinical Supply Agreement

 

[Blockhead]

Lots of promising time’s ahead I feel.
H